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Ab stra ct
Al thou gh it is widely ag reed that cli ni cia ns mu st be in for med of ab nor mal la bo ra to ry re sul ts that con sti tu te a li fe-threa te ni ng con di tion for the pa-
tie nt, as we ll as for any va lues for whi ch de lays in re por ti ng can re su lt in ad ver se out co mes for pa tien ts, the cri te ria for consi de ri ng tes ts re sul ts cri-
ti cal are con tro ver sial. Mo reo ver lar ge va ria bi li ty exis ts in de )  ni ng low and hi gh cri ti cal va lues cu t-o+ s and in no ti fyi ng them to ca re gi ve rs. In Ita ly, 
basically the cri ti cal va lues we re com mu ni ca ted to physi cia ns or de ri ng the tes ts (37.3%), nur ses (29.4%) and at a lower exte nt to any physi cian on 
ca ll (17.9%), any peop le wor ki ng in the wa rd (11.9%), and cler ks (3%). Again so me di+ e ren ces wi th the US ha ve been de mon stra ted, bei ng the no-
ti )  ca tion di rec ted al so to pa tien ts (12.2%), and even to the ge ne ral prac ti tio ner’s re la ti ves. So me in te res ti ng di+ e ren ces we re ob ser ved when com-
pa ri ng the Ita lian and US po li cies in cri ti cal va lues no ti )  ca tion. In Ita ly the no ti )  ca tion is ma de prin ci pal ly by la bo ra to ry ma na ge rs, i.e., pat ho lo gis ts, 
bio lo gis ts, doc to rs on ca ll, rat her than by la bo ra to ry tec hno lo gis ts, who pro vi de the no ti )  ca tion in on ly 11.1% of in sti tu tio ns. In tu rn, the pro fes sio-
na ls in vol ved in com mu ni ca ti ng cri ti cal va lues in US in sti tu tio ns are usual ly la bo ra to ry tec hni cia ns or tec hno lo gis ts who per for med the tes ts. The re-
por ti ng of cri ti cal va lues from the la bo ra to ry to ca re gi ve rs is sti ll ma de main ly by te lep ho ne (81.1% in the Ita lian sur vey). Le ss com mon ly used mea ns 
of com mu ni ca tion in clu ded com pu ter (10%), fax (1.1%) or all too ls in di ca ted. In the US, la bo ra to ries ha ve crea ted ca ll cen te rs in or der to cen tra li ze 
cri ti cal va lue re por ti ng.
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In tro duc tion
The la st few de ca des ha ve seen a sig ni =  ca nt dec-
rea se in the ra tes of ana lyti cal er ro rs in cli ni cal la-
bo ra to ries, and avai lab le evi den ce de mon stra tes 
that the pre- and po st-a na lyti cal ste ps of the to tal 
tes ti ng pro ce ss (TTP) are mo re er ro r-prone than 
the ana lyti cal pha se (1–3). In par ti cu lar, mo st er ro rs 
are iden ti = ed in pre-pre-a na lytic and po st-po st-
ana lytic ste ps out si de the tra di tio nal la bo ra to ry 
en vi ron me nt, and beyo nd the di re ct con trol of the 
la bo ra to ry sta E  (4). Orde ri ng and fol lowing-up on 
la bo ra to ry and ima gi ng tes ts con su mes lar ge 
amoun ts of physi cian ti me and is im por ta nt in the 
diag nos tic pro ce ss. Now, diag nos tic er ro rs are the 
mo st freque nt cau se of mal prac ti ce clai ms in the 
US, and tes ti ng-re la ted mis ta kes can lead to se-
rious diag nos tic er ro rs (5). Rece nt da ta on er ro rs in 
the pre-pre ana lyti cal pha se un der li ne that fai lu res 
to or der ap prop ria te diag nos tic tes ts, in clu di ng la-
bo ra to ry tes ts, ac coun ted for 55% of ob ser ved 
break downs in mis sed and de layed diag no sis in 
the am bu la tory set ti ng (6–8), and 58% of er ro rs in 
the Emer gen cy de par tme nt (9). In the =  nal ste ps of 
the loop, the in cor re ct in ter pre ta tion of diag nos tic 
or la bo ra to ry tes ts was fou nd to be res pon sib le for 
a hi gh per cen ta ge of er ro rs in the am bu la to ry set-
ti ng as we ll as in Emer gen cy de par tmen ts (6–9). 
Im pro vi ng qua li ty in the po st-a na lyti cal pha se rep-
re sen ts as su ch a va luab le goal for re du ci ng er ro rs 
and im pro vi ng pa tie nt sa fe ty. In par ti cu lar, is sues 
su ch as avoi di ng ma nual tran scrip tion of da ta, au-
to ma ted pro ce du res for da ta va li da tion and re por-
ti ng as we ll as the im ple men ta tion of syste ms 
whi ch al lows a mo re eE ec ti ve knowled ge ma na-
ge me nt to sup po rt da ta in ter pre ta tion and cli ni-
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cal de ci sio n-ma ki ng at the poi nt of ca re may as su-
re bet ter qua li ty and hig her pa tie nt safe ty. A key-
is sue in po st-a na lyti cal qua li ty is rep re sen ted by 
the eE ec ti ve ne ss of la bo ra to ry da ta com mu ni ca-
tion, par ti cu lar ly com mu ni ca tion of cri ti cal te st re-
sul ts (10)
Cri ti cal va lues: the con ce pt
The con ce pt of cri ti cal va lues was ori gi nal ly de = -
ned in 1972 (11) and ela bo ra ted on in 1990 (12) by 
Geor ge D. Lun dbe rg, a pat ho lo gi st who ob ser ved 
that ve ry hi gh or ve ry low ab nor mal la bo ra to ry 
va lues in di ca ted that the pa tie nt wou ld die or ha-
ve ir re pa rab le physi cal da ma ge un le ss trea ted 
im me dia te ly. In the 30 yea rs sin ce Lun dbe rg’s ob-
ser va tio ns, cri ti cal va lues re por ti ng re cei ved mo-
re fo cus and con ce rn by the la bo ra to ry scien ti = c 
com mu ni ty as we ll as by so me re gu la to ry or ga ni-
za tio ns. The con ce pt has been ad dres sed in US 
le gis la tion for cli ni cal la bo ra to ries, we ll known as 
the Cli ni cal La bo ra to ry Im pro ve me nt Amen-
dmen ts (CLIA), ini tial ly re lea sed in 1988. Mo re re-
cen tly, it was adop ted by la bo ra to ry-ac cre di ti ng 
agen cies, su ch as the Joi nt Com mis sion (JC) and 
the Col le ge of Ame ri can Pat ho lo gis ts (CAP) in the 
US and by the Cli ni cal Pat ho lo gy Ac cre di ta tion in 
the UK. The 2005 Na tio nal Pa tie nt Sa fe ty Goa ls of 
the JC, in par ti cu lar, in clu de a requi re me nt that 
heal th ca re or ga ni za tio ns mea su re, as se ss and, if 
ap prop ria te, ta ke ac tion to im pro ve the ti me li ne-
ss of re porti ng, and the ti me li ne ss of re cei pt by 
the res pon sib le li cen sed ca re gi ver, of cri ti cal te st 
re sul ts and va lues (13). Mo re re cen tly, the Wor ld 
Al lian ce for Pa tie nt Sa fe ty (WAPS) re lea sed 23 po-
ten tial pa tie nt sa fe ty so lu tion to pi cs, and one of 
the se, that is “com mu ni ca ti ng cri ti cal te st re sul ts”, 
has been se lec ted by the Wor ld Heal th Or ga ni za-
tion (WHO) In ter na tio nal Ste eri ng Com mit tee as 
a prio ri ty goal (14). The re fo re, the de =  ni tion and 
re por ti ng of cri ti cal va lues is an im por ta nt pha se 
of the cli ni cal labora to ry tes ti ng pro ce ss, and la-
bo ra to ries are res pon sib le for de tec ti ng li fe-
threa te ni ng re sul ts, for re por ti ng them to heal th 
ca re pro vi de rs, and al so for trac ki ng and im pro vi-
ng the ti me li ne ss of re por ti ng and the re cei pt of 
re sul ts. Howe ver, a con sen sus on se ve ral is sues 
re la ted to cri ti cal va lues and their com mu ni ca-
tion does not exi st. In par ti cu lar, a great va ria bi li-
ty exis ts amo ng the cri ti cal choi ce of the ana lytes, 
on the ac tual cri ti cal li mi ts, on the pro fes sio na ls 
in vol ved in cri ti cal va lues com munica tion, bo th 
in re por ti ng and re cei vi ng the da ta, and on the 
exis ten ce of writ ten pro ce du res and do cu men ta-
tion.
Cri ti cal va lues as a con tro ver sial is sue
Al thou gh it is wi de ly ag reed that cli ni cia ns mu st 
be in for med of ab nor mal la bo ra to ry re sul ts that 
consti tu te a li fe-threa te ni ng con di tion for the pa-
tie nt as we ll as for any va lues for whi ch de lays in 
re por ti ng can re su lt in ad ver se out co mes for pa-
tien ts, the cri te ria for con si de ri ng tes ts re sul ts cri ti-
cal are sti ll lar ge ly con tro ver sial.
The = r st is sue is the choi ce of the ana lytes. The re 
is no con sen sus on the mo st re liab le sour ce of in-
for ma tion re gar di ng the li st of cri ti cal va lues and 
cli ni cal la bo ra to ries may fol low bo th re com men-
da tio ns of scien ti = c so cie ties and cli ni cian’s opi-
nio ns in their in stitutio ns. The ana lytes mo re 
frequen tly in clu ded in the cri ti cal va lues li st are in 
des cen di ng frequen cy: pla te le ts, he mog lo bin, 
po tas sium, so dium, cal cium, prot hrom bin ti me 
(PT) or INR (In ter na tio nal Nor ma li zed ra tio), ac ti-
va ted par tial pro throm bin ti me (aPTT), neut rop-
hi ls, whi te blood ce ll cou nt (WBC) and mag ne-
sium (15). Of the se, so dium, mag ne sium, cal cium 
and WBC we re re por ted wi th low and hi gh cri ti-
cal cu t-oE s by all par ti ci pan ts. The INR and aPTT 
we re re por ted wi th a sin gle le vel (hi gh cu t-o E ) by 
all labo ra to ries. Tab le 1 shows the dis tri bu tion of 
cu t-o E  va lues. Da ta are expres sed as 5th per cen ti-
le cor res pon di ng to the lowe st cri ti cal va lues, 
50th that is the me dian va lue, and 95th per cen ti-
les, amo ng the Ita lian and US la bo ra to ries (Tab le 
1, Fi gu re 1).
Re por ti ng pro ce du res
The re por ti ng of cri ti cal va lues from the la bo ra to-
ry to ca re gi ve rs is sti ll ma de main ly by te lep ho ne 
(81.1% in the Ita lian sur vey). Le ss com mon ly used 
mea ns of com mu ni ca tion in clu ded com pu ter 
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Cri ti cal Va lue
Ita lian Sur vey CAP Q-Pro bes Sur vey
5th per cen ti le 50th per cen tile
(Me dian)
95th per cen ti le 5th per cen ti le 50th per cen ti le
(Me dian)
95th per cen ti le
Cal cium Hi gh 
(mmol/L) 2.7 3.2 3.5 3.0 3.3 3.5
Cal cium Low 
(mmol/L) 1.4 1.7 2.1 1.5 1.5 1.8
He mog lo bin Hi gh 
(g/L) 171 199 200 180 200 230
He mog lo bin Low 
(g/L) 50 66 84 50 70 80
Po tas sium Hi gh 
(mmol/L) 5.5 6.2 7.1 5.9 6 6.5
Po tas sium Low 
(mmol/L) 2.0 2.8 3 2.5 2.9 3.1
Mag ne sium Hi gh 
(mmol/L) 0.93 2.0 2.9 1.25 2.05 2.9
Mag ne sium Low 
(mmol/L) 0.41 0.5 0.8 0.35 0.4 0.55
So dium Hi gh 
(mmol/L) 150 160 160 150 160 170
So dium Low 
(mmol/L) 110 120 130 110 120 125
Pla te let cou nt Hi gh 
(109/L) 449 900 1500 700 999 1000
Pla te let cou nt Low 
(109/L) 10 30 85 20 31 70
Ac ti va ted par tial 
Prot hrom bin ti me (sec) 41 85 180 42 80 150
TAB LE 1. Cri ti cal va lue dis tri bu tion. (Data for Ita lian La bo ra to ries are from re fe ren ce 15, for the US La bo ra to ries from re fe ren ce 16.)
FI GU RE 1. In te r-la bo ratory va ria bi li ty of cri ti cal va lue cu t-oE s for po tas sium. Re la ti ve frequen cies for hi gh (le ft si de) and low (rig ht si-




































































5.0 5.4 5.8 6.2 6.6 6.9 7.3 7.7 8.1
2.1 2.4 2.6 2.9 3.1 3.4 3.6 3.95.2 5.6 6.0 6.4 6.7 7.1 7.5 7.9 8.3
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(10%), fax (1.1%) or all too ls in di ca ted (15). In the 
US, la bo ra to ries ha ve crea ted ca ll cen te rs in or der 
to cen tra li ze cri ti cal va lue re por ti ng (17). In our in-
sti tu tio ns, we ha ve in tro du ced a com pu te ri zed 
no ti =  ca tion system usi ng the la bo ra to ry (LIS) and 
hos pi tal cli ni cal in for ma tion syste ms (HCIS). Brief-
ly, on ce a cri ti cal va lue has been iden ti = ed and 
va li da ted by the cli ni cal pat ho lo gi st in char ge, 
the tran smis sion from the LIS to HCIS system 
crea tes an e-mail mes sa ge for au to ma ted no ti = -
ca tion. On the HCIS pa tie nt re co rd, this e-mail for 
critical va lue no ti =  ca tion ge ne ra tes two ac tio ns: 
an SMS to the ce ll pho ne of the re fer ri ng physi-
cian (bo th for in- and ou t-pa tien ts) and at the de-
par tmen tal le vel, an ale rt mes sa ge by vi deo to 
the or de ri ng cli ni cian. This au to ma ted com mu ni-
ca tion has im pro ved the ti me li ne ss of no ti =  ca-
tion, and al so pre ven ted po ten tial er ro rs for whi-
ch ac cre di ta tion prog ra ms requi re rea d-ba ck of 
the re sul ts. Mo reo ver, it im pro ved the li ke li hood 
of reac hi ng the physi cian on ca ll or the ge ne ral 
prac ti tio ner and may pro vi de im porta nt de ci sion 
sup po rt (18).
Some in te res ti ng diE e ren ces we re ob ser ved when 
com pa ri ng the Ita lian and US po li cies in cri ti cal va-
lues no ti =  ca tion. In Ita ly the no ti =  ca tion is ma de 
prin ci pal ly by la bo ra to ry ma na ge rs, i.e., pat ho lo-
gis ts, bio lo gis ts, doc to rs on ca ll, rat her than by la-
bo ra to ry tec hno lo gis ts, who pro vi de the no ti =  ca-
tion in on ly 11.1% of in sti tu tio ns (15). On the ot her 
ha nd, in the US in sti tu tio ns the pro fes sio na ls in vol-
ved in com mu ni ca ti ng cri ti cal va lues are usual ly la-
bo ra to ry tec hni cia ns or tec hno lo gis ts who per for-
med the tes ts (16).
In Ita ly, the cri ti cal va lues we re com mu ni ca ted to 
phy si cia ns or de ri ng the tes ts (37.3%), nur ses 
(29.4%) and at a lower exte nt to any physi cian on 
ca ll (17.9%), any peop le wor ki ng in the wa rd 
(11.9%), and cler ks (3%) (15). Again so me diE e ren-
ces wi th the US ha ve been de mon stra ted, bei ng 
the no ti =  ca tion di rec ted al so to pa tien ts (12.2%), 
and even to the ge ne ral prac ti tio ner’s re la ti ves 
(16).
Ac cor di ng to the in clu sion of cri ti cal va lues com-
mu ni ca tion amo ng requiremen ts of avai lab le stan-
dar ds for ac cre di ta tion of cli ni cal la bo ra to ries (19), 
72.2% of Ita lian la bo ra to ries par ti ci pa ti ng in the 
sur vey in di ca ted that writ ten pro ce du res we re in 
pla ce in their in sti tu tio ns for cri ti cal va lues iden ti = -
ca tion and re por ti ng (15); 90% in di ca ted that the 
ti me li ne ss of re por ti ng is re gu lar ly as ses sed but 
on ly 63.35% of la bo ra to ries up da te their pro ce du-
res at es tab lis hed ti mes.
Con clu sio ns
A re ce nt stu dy de mon stra ted that fai lu res to in fo-
rm pa tien ts on cli ni cal ly sig ni =  ca nt abnormal te st 
re sul ts or to do cu me nt that they ha ve been in for-
med ap pear to be re la ti ve ly com mon, oc cur ri ng 
in 1 of eve ry 14 tes ts (20). Fai lu res in vol ved com-
mon la bo ra to ry tes ts su ch as ab nor mal thyrot ro-
pin (T4), po tas sium, blood glu co se le ve ls and he-
ma to crit. An even mo re re ce nt stu dy do cu men-
ted that 10.9% of cri ti cal pa tie nt ca re ite ms we re 
lo st du ri ng a 24-hour ob ser va tion pe riod due to 
fai lu res of com mu ni ca tion (21). Amo ng the ca te-
go ries of da ta lo st in cri ti cal pa tie nt ma na ge me-
nt, cri ti cal la bo ra to ry values and te st re sul ts we re 
mo st frequen tly lo st du ri ng the con trol pe riod 
(36.1% of lo st ob ser va tio ns). Im pro ve men ts in 
com mu ni ca tion of la bo ra to ry re sul ts, par ti cu lar ly 
cri ti cal re sul ts, seem to be nee ded for re du ci ng 
er ro rs and im pro vi ng pa tie nt sa fe ty. Althou gh 
the con ce pt of cri ti cal va lues has been in tro du-
ced in the me di cal com mu ni ty ma ny yea rs ago, 
cur re nt da ta de mon stra te a la ck of har mo ni za-
tion bo th in de =  ni ng the ana lytes as we ll as low 
and hi gh cri ti cal va lues cu t-oE s. Mo reo ver, the 
po li cies used for no ti fyi ng cri ti cal va lues wi de ly 
va ry amo ng la bo ra to ries in the sa me Coun try 
and when com pa ri ng the US wi th the Ita lian si-
tua tion. It has been stres sed that in for ma ti cs may 
aid to re du ce fai lu re ra tes in no ti =  ca tion of ab nor-
mal te st re sul ts, na me ly crucial va lues (22). In ad-
di tion, few da ta exi st usi ng la bo ra to ry cri ti cal va-
lues to eva lua te va ria tio ns in pa tie nt ad ver se 
even ts. In a re ce nt stu dy, howe ver, cri ti cal va lues 
we re plot ted over ti me on sta tis ti cal con trol char-
ts and ana lyzed for unu sual peaks in mon thly oc-
cur ren ce ra tes, de mon stra ti ng the abi li ty to ra-
pid ly de te ct ad ver se even ts, thus fa ci li ta ti ng ti-
me ly in ves ti ga tion (23). The re fo re, eE or ts shou ld 
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be do ne for im pro vi ng ac tual con sen sus on the 
de =  ni tion and no ti =  ca tion of la bo ra to ry critical 
va lues (e.g., that en dor sed by the Ita lian So cie ty 
of Cli ni cal Bioc he mis try and Mo le cu lar Bio lo gy 
[SIBioC]) (24,25), and for eva lua ti ng their con tri-
bu tion to im pro ve cli ni cal out co mes and pa tie nt 
sa fe ty.
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Priopćava nje kri tičnih vri jed nos ti
Sažetak
Ia ko je naširo ko prih vaćeno mišlje nje stručnja ka ka ko kli ničari mo ra ju bi ti oba vi ješte ni o pa to loškim la bo ra to rij skim na la zi ma ko ji pred stav lja ju 
sta nje ko je ug rožava život bo les ni ku, kao i o bi lo ko joj dru goj vrijed nos ti čije za kašnje lo iz vješta va nje može oz bilj no ug ro zi ti bo les ni ko vo zdrav-
lje, o kri te ri ji ma za od ređiva nje je li na laz kri tičan još se uvi jek ras prav lja. Što više, pos to ji ve li ka va ri ja bil no st u de )  ni ra nju nis ke i vi so ke gra nične 
kri tične vri jed no sti, te u iz vješta va nju li ječni ci ma. U Ita li ji su se o kri tičnim vri jed nos ti ma iz vješta va li od go vor ni li ječnici (37,3%), me di cin ske ses-
tre (29,4%), te u ma njoj mje ri, bi lo ko ji dežur ni li ječnik na od je lu (17,9%), osob lje s od je la (11,9%) i službe ni ci (3,0%). U us po red bi s ame ričkim 
is kus tvom mo gu se pri mi je ti ti ne ke raz li ke, gdje su se te oba vi jes ti pre no si le sa mim bo les ni ci ma (12,2%), pa čak i rođaci ma li ječni ka o pće prak se. 
Us po ređujući ta li jan ske i ame ričke pos tup ke prio pćava nja kri tičnih vri jed nos ti, mo gu se pri mi je ti ti za nim lji ve raz li ke. U Ita li ji prio pćava nje ug lav-
nom obav lja ju vo di te lji la bo ra to ri ja, od nos no pa to lo zi, bio lo zi, dežur ni li ječni ci, a u ma njoj mje ri la bo ra to rij ski teh ničari, ko ji pre no se oba vi je st tek 
u 11,1% is pi ta nih us ta no va. Za raz li ku od Ita li je, u SAD su la bo ra to rij ski teh ničari ili teh no lo zi ko ji su nap ra vi li pret ra ge obično oso be ko je iz vješta-
va ju o kri tičnim vri jed nos ti ma. Priopćava nje kri tičnih vri jed nos ti još se uvi jek pre težno od vi ja te lefon skim pu tem (81,1% u ta li jan skom is pi ti va-
nju). Rjeđi način ko mu ni ka ci je je pu tem računa la (10%), fax uređaja (1,1%) ili svih os ta lih na ve de nih sred sta va. U SAD su la bo ra to ri ji or ga ni zi ra li 
po ziv ne cen tre ka ko bi se cen tra li zi ralo prio pćava nje kri tičnih vri jed nos ti.
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